Graves' disease risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}};{{AE}}{{MehdiP}}
{{CMG}};{{AE}}{{MehdiP}}
==Overview==
==Overview==
The most potent risk factor in the development of Graves' disease is genetic susceptibility. Other risk factors include infections, stress and smoking.
The most potent risk factor in the development of Graves' disease is genetic susceptibility. Other risk factors include infections, stress and [[smoking]].
== Risk Factors ==
== Risk Factors ==
This table summarizes the risk factors for Graves' disease.
This table summarizes the risk factors for Graves' disease.
Line 12: Line 12:
|Genetic susceptibility
|Genetic susceptibility
|
|
* Association with immune related genes (i.e. CTLA-4).<ref name="pmid14570752">{{cite journal |vauthors=Tomer Y, Davies TF |title=Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function |journal=Endocr. Rev. |volume=24 |issue=5 |pages=694–717 |year=2003 |pmid=14570752 |doi=10.1210/er.2002-0030 |url=}}</ref>
* Association with immune related genes (i.e. [[CTLA-4]]).<ref name="pmid14570752">{{cite journal |vauthors=Tomer Y, Davies TF |title=Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function |journal=Endocr. Rev. |volume=24 |issue=5 |pages=694–717 |year=2003 |pmid=14570752 |doi=10.1210/er.2002-0030 |url=}}</ref>
* Association with certain alleles of human leukocyte  
* Association with certain alleles of [[human leukocyte antigen]] (HLA) on chromosome 6.<ref name="pmid12973666">{{cite journal |vauthors=Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF |title=Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families |journal=Am. J. Hum. Genet. |volume=73 |issue=4 |pages=736–47 |year=2003 |pmid=12973666 |pmc=1180598 |doi=10.1086/378588 |url=}}</ref>  
antigen (HLA) on chromosome 6.<ref name="pmid12973666">{{cite journal |vauthors=Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF |title=Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families |journal=Am. J. Hum. Genet. |volume=73 |issue=4 |pages=736–47 |year=2003 |pmid=12973666 |pmc=1180598 |doi=10.1086/378588 |url=}}</ref>
 
* The concordance rate in monozygotic twins is 20 to 40 percent.
* The concordance rate in monozygotic twins is 20 to 40 percent.
|-
|-
|Infection
|Infection
|There are some possible infection that may predispose patient to Graves' disease
|There are some possible infection that may predispose patient to Graves' disease
* Congenital rubella
* [[Congenital rubella]]
* Hepatitis C<ref name="pmid21297381">{{cite journal |vauthors=Menconi F, Hasham A, Tomer Y |title=Environmental triggers of thyroiditis: hepatitis C and interferon-α |journal=J. Endocrinol. Invest. |volume=34 |issue=1 |pages=78–84 |year=2011 |pmid=21297381 |doi=10.1007/BF03346699 |url=}}</ref>
* [[Hepatitis C]]<ref name="pmid21297381">{{cite journal |vauthors=Menconi F, Hasham A, Tomer Y |title=Environmental triggers of thyroiditis: hepatitis C and interferon-α |journal=J. Endocrinol. Invest. |volume=34 |issue=1 |pages=78–84 |year=2011 |pmid=21297381 |doi=10.1007/BF03346699 |url=}}</ref>
|-
|-
|Stress
|Stress

Revision as of 18:39, 31 March 2017

Graves' disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Graves' disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Approach

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Hyperthyroidism
Ophtalmopathy
Dermopathy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Graves' disease risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Graves' disease risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Graves' disease risk factors

CDC on Graves' disease risk factors

Graves' disease risk factors in the news

Blogs on Graves' disease risk factors

Directions to Hospitals Treating Graves' disease

Risk calculators and risk factors for Graves' disease risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

The most potent risk factor in the development of Graves' disease is genetic susceptibility. Other risk factors include infections, stress and smoking.

Risk Factors

This table summarizes the risk factors for Graves' disease.

Risk Factors Graves' disease
Genetic susceptibility
  • The concordance rate in monozygotic twins is 20 to 40 percent.
Infection There are some possible infection that may predispose patient to Graves' disease
Stress Some psychotic stress disorders are more common among Graves' patients.[4][5]
Smoking It is associated with Graves' diseases and its' ophtalmopathy.[6]


References

  1. Tomer Y, Davies TF (2003). "Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function". Endocr. Rev. 24 (5): 694–717. doi:10.1210/er.2002-0030. PMID 14570752.
  2. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF (2003). "Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families". Am. J. Hum. Genet. 73 (4): 736–47. doi:10.1086/378588. PMC 1180598. PMID 12973666.
  3. Menconi F, Hasham A, Tomer Y (2011). "Environmental triggers of thyroiditis: hepatitis C and interferon-α". J. Endocrinol. Invest. 34 (1): 78–84. doi:10.1007/BF03346699. PMID 21297381.
  4. Matos-Santos A, Nobre EL, Costa JG, Nogueira PJ, Macedo A, Galvão-Teles A, de Castro JJ (2001). "Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre". Clin. Endocrinol. (Oxf). 55 (1): 15–9. PMID 11453947.
  5. Sonino N, Girelli ME, Boscaro M, Fallo F, Busnardo B, Fava GA (1993). "Life events in the pathogenesis of Graves' disease. A controlled study". Acta Endocrinol. 128 (4): 293–6. PMID 8498147.
  6. Bartalena L, Tanda ML (2009). "Clinical practice. Graves' ophthalmopathy". N. Engl. J. Med. 360 (10): 994–1001. doi:10.1056/NEJMcp0806317. PMID 19264688.

Template:WH Template:WS